Several studies have suggested that the measurement of structurally modified albumin could assist with monitoring oxidative stress in several clinical conditions, such as renal failure, ischemic heart disease, acute appendicitis, cerebral infarction, and pre-eclampsia [19,20,21,22,23]. The gene discussed is ALB; the disease is Renal insufficiency.